Table 1 Comparison of clinical and laboratory parameters according to KDPI score and the age of KTRs.
Variables | Low KDPI- young KT | Low KDPI- elderly KT | High KDPI-young KT | High KDPI-elderly KT | p for Trend |
|---|---|---|---|---|---|
Donors | n = 239 | n = 30 | n = 196 | n = 61 | |
Age at KT (years) | 35.6 ± 12.3 | 34.2 ± 12.5 | 53.8 ± 8.9 | 59.1 ± 7.5 | <0.001 |
Gender (Male: Female) | 173: 66 | 24: 6 | 132: 64 | 39: 22 | 0.292 |
Body mass index (kg/m2) | 23.0 ± 4.1 | 23.3 ± 3.7 | 23.2 ± 3.3 | 22.9 ± 2.7 | 0.457 |
Hypertension, n (%) | 9 (3.8) | 2 (6.7) | 76 (38.8) | 20 (32.8) | <0.001 |
Diabetes mellitus, n (%) | 6 (2.5) | 0 | 34 (17.3) | 10 (16.4) | <0.001 |
Cause of donor death - CVA, n (%) | 151 (63.2) | 16 (53.3) | 145 (74.0) | 51 (83.6) | 0.001 |
Baseline GFR (ml/min/1.73m2) (CKD-EPI) | 116.7 ± 35.7 | 117.9 ± 44.9 | 117.7 ± 28.7 | 118.9 ± 30.0 | 0.726 |
Acute kidney injury, n (%) | 95 (39.7) | 18 (60.0) | 141 (71.9) | 39 (63.9) | <0.001 |
Recipients | n = 285 | n = 34 | n = 262 | n = 76 | |
Transplant year, n (%) | 0.012 | ||||
1996 ~ 2005 | 8 (2.8) | 0 | 0 | 0 | |
2006 ~ 2010 | 51 (17.9) | 3 (8.8) | 37 (14.1) | 4 (5.3) | |
2011 ~ 2017 | 226 (79.3) | 31 (91.2) | 225 (85.9) | 72 (94.7) | |
Age at KT (yr) | 45.7 ± 8.4 | 63.7 ± 2.7 | 47.8 ± 8.5 | 63.6 ± 3.2 | <0.001 |
Gender (Male: Female) | 168: 117 | 20: 14 | 155: 107 | 46: 30 | 0.997 |
Body mass index (kg/m2) | 22.9 ± 4.1 | 23.9 ± 3.1 | 23.4 ± 3.6 | 23.1 ± 3.1 | 0.312 |
Hypertension, n (%) | 232 (81.4) | 31 (91.2) | 224 (85.5) | 66 (86.8) | 0.348 |
Diabetes mellitus, n (%) | 46 (16.1) | 9 (26.5) | 64 (24.4) | 18 (23.7) | 0.063 |
Dialysis duration, years | 9.0 ± 9.0 | 7.0 ± 3.7 | 8.2 ± 13.0 | 6.9 ± 4.3 | 0.355 |
Previous KT, n (%) | 41 (14.4) | 4 (11.8) | 22 (8.4) | 3 (3.9) | 0.023 |
Cause of ESRD, n (%) | <0.001 | ||||
Glomerulonephritis | 149 (52.3) | 7 (20.6) | 104 (39.7) | 38 (50.0) | |
Diabetes mellitus | 35 (12.3) | 9 (26.5) | 51 (19.5) | 19 (25.0) | |
Hypertension | 37 (13.0) | 8 (23.5) | 60 (22.9) | 10 (13.2) | |
Others | 64 (22.5) | 10 (29.4) | 47 (17.9) | 9 (11.8) | |
Cold ischemic time (min) | 255.3 ± 127.4 | 245 .2 ± 149.9 | 246.0 ± 119.3 | 254.9 ± 117.1 | 0.836 |
HLA mismatch number | 3.5 ± 1.5 | 3.4 ± 1.6 | 3.8 ± 1.5 | 3.8 ± 1.5 | 0.101 |
Induction, n (%) | 0.045 | ||||
Basiliximab | 217 (76.1) | 22 (64.7) | 174 (66.4) | 50 (65.8) | |
Anti-thymocyte globulin | 68 (23.9) | 12 (35.3) | 88 (33.6) | 26 (34.2) | |
Main immunosuppressant, n (%) | |||||
Tacrolimus: Cyclosporine | 278: 6 | 34: 0 | 259: 3 | 76: 0 | 0.733 |
PRA > 50% | 32 (19.5) | 4 (20.0) | 27 (13.9) | 6 (15.4) | 0.491 |